Page last updated: 2024-09-05

sb 203580 and Leishmaniasis, Visceral

sb 203580 has been researched along with Leishmaniasis, Visceral in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Junghae, M; Raynes, JG	1

Other Studies

1 other study(ies) available for sb 203580 and Leishmaniasis, Visceral

Article	Year
Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infection and immunity, 2002, Volume: 70, Issue:9 Topics: Animals; Anisomycin; Antiprotozoal Agents; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; In Vitro Techniques; Leishmania donovani; Leishmaniasis, Visceral; Lipopolysaccharides; Macrophages; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction	2002

Article

Year

Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages.

Infection and immunity, 2002, Volume: 70, Issue:9

Topics: Animals; Anisomycin; Antiprotozoal Agents; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; In Vitro Techniques; Leishmania donovani; Leishmaniasis, Visceral; Lipopolysaccharides; Macrophages; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction

2002